Medical Education Library

BEST PRACTICES: An Oral Treatment for Moderate to Severe Plaque Psoriasis


 

A Best Practices Supplement to Dermatology News. This supplement was sponsored by Celgene Corporation.

Faculty/Faculty Disclosures

Alan Menter, MD
Baylor University Medical Center
Dallas, TX

Dr Menter is on the advisory board for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Eli Lilly, Genentech Inc., Janssen Biotech, Inc., LEO Pharma and Pfizer; is a consultant for AbbVie, Allergan, Amgen, Convoy Therapeutics, Inc., Eli Lilly, Janssen Biotech, Inc., LEO Pharma, Novartis, Pfizer, Syntrix, Vitae, Wyeth and XenoPort; is an investigator for AbbVie, Allergan, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen Biotech, Inc., LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho, Syntrix and Wyeth; is a speaker for AbbVie, Amgen, Janssen Biotech, Inc., LEO Pharma and Wyeth; has received grant funds from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Celgene, Genentech, Janssen Biotech, Inc., LEO Pharma, Merck, Novartis, Pfizer, Symbio/Maruho and Syntrix; and has received honoraria from AbbVie, Allergan, Amgen, Boehringer Ingelheim, Convoy Therapeutics, Inc., Eli Lilly, Genentech, Janssen Biotech, Inc., LEO Pharma, Novartis, Pfizer, Syntrix, Vitae, Wyeth and XenoPort.

Copyright © by Frontline Medical Communications Inc.

Recommended Reading

Nonmelanoma skin cancer initially misdiagnosed in 36% of small cohort
MDedge Dermatology
Personalized and Precision Medicine: How Will This Impact People With Rare Diseases?
MDedge Dermatology
Advancing Therapies for Rare Diseases Act is Introduced
MDedge Dermatology
FDA Releases Rare Disease Draft Guidance Document
MDedge Dermatology
NIH Undiagnosed Diseases Network Launches Online Application Portal
MDedge Dermatology
OnabotulinumtoxinA associated with reduced severity of PAH
MDedge Dermatology
Malpractice premiums flat in 2015, but changes could be ahead
MDedge Dermatology
Resident Involvement in Policy-Making
MDedge Dermatology
Vulvar Diseases, Part 2
MDedge Dermatology
Topical calcipotriene-betamethasone combination approved for plaque psoriasis
MDedge Dermatology